statement of cash flows

ASC 230-915 formerly required a development stage entity to present inception-to-date (cumulative) amounts in its statement of cash flows in addition to the amounts for the current period. Every paragraph in the subtopic (230-915-05-1, 15-1, and 45-1) was superseded by ASU 2014-10, which eliminated the development stage entity reporting concept from U.S. GAAP. As a result, entities formerly in the development stage now prepare a statement of cash flows under ASC 230 exactly like any other entity, with no cumulative-since-inception column.

This subtopic provides implementation guidance for how not-for-profit entities (NFPs) prepare a statement of cash flows under Topic 230. It addresses when otherwise-qualifying short-term investments cannot be treated as cash equivalents because of donor restrictions, how donor-restricted contributions for long-term purposes must be reclassified as financing inflows, and how agency transactions, noncash contributions, and collection items are reported.

This subtopic governs how entities engaged in real estate time-sharing activities classify cash flows related to time-sharing notes receivable. The core rule is that all changes in time-sharing notes receivable — including cash received from selling those notes — are reported as operating activities in the statement of cash flows (230-978-45-1), rather than as investing or financing activities.

ASC 305-10 is the Overall subtopic of the Cash and Cash Equivalents topic, but its substantive content has been removed — the scope, overview, and implementation guidance paragraphs were superseded by Maintenance Update 2017-21 and ASU 2012-04. As a result, 305-10 today functions largely as a placeholder heading; the operative guidance on cash and cash equivalents lives elsewhere, principally in ASC 230 (definition and presentation of cash equivalents, restricted cash) and ASC 210 (balance sheet classification).

ASC 305-942 was the industry-specific guidance on cash and cash equivalents for depository and lending institutions (banks, savings institutions, credit unions). Every paragraph in the subtopic — scope, presentation, and disclosure — was superseded by Maintenance Update 2017-21, so the subtopic contains no operative guidance. Entities in this industry now apply the general guidance in ASC 305 and, for restricted/reserve balances and cash flow classification, ASC 942-305 and ASC 230.

ASC 305-946 was the investment-company-specific guidance on cash and cash equivalents. Every remaining paragraph (05-1, 15-1, 45-1, 45-2) was superseded by Maintenance Update 2017-21, so the subtopic contains no substantive guidance today. Investment companies now look to the general cash guidance in ASC 305 and to the presentation and disclosure requirements in ASC 946.

ASC 305-954 was the health care industry-specific guidance on cash and cash equivalents, but it now contains no operative content — every paragraph has been superseded or is unused. Health care entities therefore follow the general guidance in Topic 305 together with the broader health care presentation rules in Topic 954.